Genetic susceptibility to Common Lipid Disorders in Mexico
墨西哥常见脂质疾病的遗传易感性
基本信息
- 批准号:7247206
- 负责人:
- 金额:$ 34.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:10q16q20qAmericanApolipoproteins BAtherosclerosisCandidate Disease GeneCaucasiansCaucasoid RaceCause of DeathCholesterolChromosomesCitiesCollaborationsCoronary heart diseaseDNADNA SequenceDataDiabetes MellitusDiseaseDyslipidemiasFamilial Combined HyperlipidemiaFamilyGenesGeneticGenetic Predisposition to DiseaseGenome ScanHealthcare SystemsHepaticHigh Density Lipoprotein CholesterolHyperlipidemiaInstitutesInternationalInvestigationLinkLipidsLos AngelesMexicanMexican AmericansMexicoMinorityNon-Insulin-Dependent Diabetes MellitusNuclearPilot ProjectsPlatelet Factor 4PopulationPredispositionPrevalencePublishingResearch PersonnelRisk FactorsRoleSerumSusceptibility GeneTimeTriglyceridesUnited StatesVariantgenetic variantgenome wide association studylipid disordernovelprogramsrapid growthtraittranscription factor USF
项目摘要
DESCRIPTION (provided by applicant): Coronary heart disease (CHD) is the leading cause of death in both the U.S and Mexico. Unfavorable serum lipid levels, such as high serum total cholesterol, high serum triglycerides and low high-density lipoprotein cholesterol, are well-known risk factors for CHD. Although several studies have demonstrated that the Mexican population has an increased predisposition to dyslipidemias, this population is underinvestigated for the genetic factors conferring this susceptibility. Considering the rapid growth of the Mexican-American population in the U.S., investigation of these genetic factors in the Mexican population is of great importance and relevant also to this U.S. minority. To identify genetic variants that confer susceptibility to high serum lipid levels in Mexicans, we recently began an international collaboration between investigators at UCLA, Los Angeles, and Institute Nacional de Ciencias Medicas y Nutricion, Mexico City. We examined 24 extended Mexican familial combined hyperlipidemia (FCHL) families for one gene and seven chromosomal loci previously detected for FCHL in Caucasian families. FCHL is the most common mixed dyslipidemia predisposing to CHD, with an estimated prevalence of 8% in Mexicans. We demonstrated that the upstream transcription factor 1 (USF1) gene and chromosomal loci on 10q and 16q are implicated in the Mexican FCHL families (Huertas-Vazquez et al. 2005). This study is the first one to extensively investigate the genetic component of the FCHL disorder in Mexicans. Recently, we also identified significant associations between DMA variants in the hepatic nuclear factor 4, alpha (HNF4A) gene and FCHL in Mexicans. Although HNF4A variants have previously been associated with type 2 diabetes mellitus (T2DM), our data show for the first time that the HNF4A variants are associated with serum lipid levels. Considering the clear phenotypic overlap between T2DM and FCHL, we hypothesize that HNF4A is a good candidate gene for FCHL as weJI. We propose to identify novel susceptibility loci for common lipid disorders in Mexicans and further examine these implicated genes. In Specific Aim 1, we will perform a genome scan in Mexican FCHL families to identify additional susceptibility loci undiscovered or nonexistent in the previously studied Caucasian populations. In Specific Aim 2, we will investigate USF1, HNF4A and the chromosomal loci implicated in the genome scan to characterize the DNA variants conferring the susceptibility to FCHL in Mexicans.
描述(由申请人提供):冠心病(CHD)是美国和墨西哥的主要死亡原因。不利的血脂水平,如高血清总胆固醇,高血清甘油三酯和低高密度脂蛋白胆固醇,是众所周知的冠心病的危险因素。虽然几项研究表明,墨西哥人口有增加的易感性血脂异常,这一人口是调查不足的遗传因素赋予这种易感性。考虑到美国墨西哥裔美国人人口的快速增长,在墨西哥人群中调查这些遗传因素是非常重要的,也与这个美国少数民族有关。为了确定墨西哥人对高血脂水平易感的遗传变异,我们最近开始了洛杉矶加州大学洛杉矶分校和墨西哥城国家科学医学和营养研究所的研究人员之间的国际合作。我们研究了24个扩展的墨西哥家族性混合型高脂血症(FCHL)家族的一个基因和7个染色体位点先前检测到的FCHL在高加索家庭。FCHL是最常见的混合性血脂异常,易患冠心病,估计在墨西哥人中的患病率为8%。我们证明了上游转录因子1(USF 1)基因和10 q和16 q上的染色体位点与墨西哥FCHL家族有关(Huertas-Vazquez et al. 2005)。这项研究是第一个广泛调查墨西哥人FCHL疾病遗传成分的研究。最近,我们还确定了墨西哥人肝核因子4 α(HNF 4A)基因的DMA变体与FCHL之间的显著关联。尽管HNF 4A变异体以前与2型糖尿病(T2 DM)相关,但我们的数据首次显示HNF 4A变异体与血脂水平相关。考虑到T2 DM和FCHL之间明显的表型重叠,我们假设HNF 4A是FCHL的良好候选基因,如weJI。我们建议识别墨西哥人常见脂质疾病的新易感基因座,并进一步检查这些相关基因。在具体目标1中,我们将在墨西哥FCHL家族中进行基因组扫描,以确定先前研究的高加索人群中未发现或不存在的其他易感性位点。在具体目标2中,我们将研究USF 1,HNF 4A和基因组扫描中涉及的染色体位点,以表征墨西哥人对FCHL易感性的DNA变异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paivi Pajukanta其他文献
Paivi Pajukanta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paivi Pajukanta', 18)}}的其他基金
Multimodal omics approach to identify health to cardiometabolic disease transitions
多模式组学方法确定健康状况向心脏代谢疾病的转变
- 批准号:
10753664 - 财政年份:2023
- 资助金额:
$ 34.94万 - 项目类别:
Genetic Background of Metabolic Syndrome-Related Traits
代谢综合征相关特征的遗传背景
- 批准号:
8001172 - 财政年份:2010
- 资助金额:
$ 34.94万 - 项目类别:
Genetics of high serum triglycerides and related metabolic traits in Mexicans
墨西哥人高血清甘油三酯的遗传学及相关代谢特征
- 批准号:
8460151 - 财政年份:2009
- 资助金额:
$ 34.94万 - 项目类别:
Genetics of high serum triglycerides and related metabolic traits in Mexicans
墨西哥人高血清甘油三酯的遗传学及相关代谢特征
- 批准号:
8284396 - 财政年份:2009
- 资助金额:
$ 34.94万 - 项目类别:
Genetics of high serum triglycerides and related metabolic traits in Mexicans
墨西哥人高血清甘油三酯的遗传学及相关代谢特征
- 批准号:
7800431 - 财政年份:2009
- 资助金额:
$ 34.94万 - 项目类别:
Genetics of high serum triglycerides and related metabolic traits in Mexicans
墨西哥人高血清甘油三酯的遗传学及相关代谢特征
- 批准号:
7572443 - 财政年份:2009
- 资助金额:
$ 34.94万 - 项目类别:
Genetics of high serum triglycerides and related metabolic traits in Mexicans
墨西哥人高血清甘油三酯的遗传学及相关代谢特征
- 批准号:
8067744 - 财政年份:2009
- 资助金额:
$ 34.94万 - 项目类别:
Familial Combined Hyperlipidemia: Genetic Background
家族性混合性高脂血症:遗传背景
- 批准号:
7344753 - 财政年份:2007
- 资助金额:
$ 34.94万 - 项目类别:
Genetic susceptibility to Common Lipid Disorders in Mexico
墨西哥常见脂质疾病的遗传易感性
- 批准号:
7656874 - 财政年份:2006
- 资助金额:
$ 34.94万 - 项目类别:
Genetic susceptibility to Common Lipid Disorders in Mexico
墨西哥常见脂质疾病的遗传易感性
- 批准号:
7440183 - 财政年份:2006
- 资助金额:
$ 34.94万 - 项目类别:
相似海外基金
16q hemizygous loss in breast cancer: The central driver for tumor initiation, invasion and progression
乳腺癌16q半合子缺失:肿瘤发生、侵袭和进展的核心驱动因素
- 批准号:
452128 - 财政年份:2021
- 资助金额:
$ 34.94万 - 项目类别:
Operating Grants
Project 1: The biochemical, topological and functional impact of cancer associated Ctcfmutations and their contribution to cancer
项目 1:癌症相关 Ctcf 突变的生化、拓扑和功能影响及其对癌症的贡献
- 批准号:
10652280 - 财政年份:2019
- 资助金额:
$ 34.94万 - 项目类别:
Project 1: The biochemical, topological and functional impact of cancer associated Ctcfmutations and their contribution to cancer
项目 1:癌症相关 Ctcf 突变的生化、拓扑和功能影响及其对癌症的贡献
- 批准号:
10153721 - 财政年份:2019
- 资助金额:
$ 34.94万 - 项目类别:
Project 1: The biochemical, topological and functional impact of cancer associated Ctcfmutations and their contribution to cancer
项目 1:癌症相关 Ctcf 突变的生化、拓扑和功能影响及其对癌症的贡献
- 批准号:
10402271 - 财政年份:2019
- 资助金额:
$ 34.94万 - 项目类别:
Chromosome 16q, a Cancer Suppressor Chromosome Arm
16q 染色体,抑癌染色体臂
- 批准号:
344719 - 财政年份:2016
- 资助金额:
$ 34.94万 - 项目类别:
Operating Grants
Transcriptome in Huntington's disease and Huntington's disease-like 2
亨廷顿病和类亨廷顿病 2 的转录组
- 批准号:
8390995 - 财政年份:2012
- 资助金额:
$ 34.94万 - 项目类别:
Transcriptome in Huntington's disease and Huntington's disease-like 2
亨廷顿病和类亨廷顿病 2 的转录组
- 批准号:
8474851 - 财政年份:2012
- 资助金额:
$ 34.94万 - 项目类别:
Validation of copy number changes by MLPA as predictors of relapse in Wilms tumor
验证 MLPA 的拷贝数变化作为肾母细胞瘤复发的预测因素
- 批准号:
8330806 - 财政年份:2011
- 资助金额:
$ 34.94万 - 项目类别:
Validation of copy number changes by MLPA as predictors of relapse in Wilms tumor
验证 MLPA 的拷贝数变化作为肾母细胞瘤复发的预测因素
- 批准号:
8028602 - 财政年份:2011
- 资助金额:
$ 34.94万 - 项目类别:
P1 - Clinical Correlations of WTX Inactivation in Wilms Tumor
P1 - 肾母细胞瘤中 WTX 失活的临床相关性
- 批准号:
8079677 - 财政年份:2010
- 资助金额:
$ 34.94万 - 项目类别: